SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registry

Zhang, 2020, Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China, Allergy, 75, 1730, 10.1111/all.14238 Qingxian C., Fengjuan C., Fang L., Xiaohui L., Tao W., Qikai W., et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Preprint at SSRN 2020. https://doiorg/102139/ssrn3556658. Garg, 2020, Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, March 1-30, 2020, MMWR Morb Mortal Wkly Rep., 69, 458, 10.15585/mmwr.mm6915e3 Alqahtani, 2020, Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis, PLoS ONE, 15, 10.1371/journal.pone.0233147 Lee, 2004, Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients, J Clin Virol, 31, 304, 10.1016/j.jcv.2004.07.006 Russell, 2020, Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury, Lancet, 395, 473, 10.1016/S0140-6736(20)30317-2 Leung, 2020, ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19, Eur Respir J, 55, 10.1183/13993003.00688-2020 Li, 2003, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, 426, 450, 10.1038/nature02145 Medina M, Babiuch C, Card M, Gavrilescu R, Zafirau W, Boose E, et al. Home monitoring for COVID-19. Cleve Clin J Med. 2020; doi:10.3949/ccjm.87a.ccc028. [published online ahead of print, 2020 Jun 11]. Arentz, 2020, Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state, JAMA: J Am Med Assoc, 10.1001/jama.2020.4326 Bhatraju, 2020, Covid-19 in critically ill patients in the Seattle region - case series, N Engl J Med, 10.1056/NEJMoa2004500 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 10.1056/NEJMoa2002032 Lauer, 2020, The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application, Ann Intern Med, 10.7326/M20-0504 Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72314 cases from the chinese center for disease control and prevention, JAMA, 10.1001/jama.2020.2648 Milinovich, 2018, Extracting and utilizing electronic health data from fpic for research, Ann Transl Med, 6, 42, 10.21037/atm.2018.01.13 Mehta, 2020, Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19), JAMA Cardiol, 10.1001/jamacardio.2020.1855 Xing, 2020, Precautions are needed for covid-19 patients with coinfection of common respiratory pathogens, medRxiv. Titmarsh, 2019, Breathing new life into chronic obstructive pulmonary disease (COPD)" - results from an online survey of UK patients, Int J Chron Obstruct Pulmon Dis, 14, 2799, 10.2147/COPD.S222139 Buuren, 2011, Mice: multivariate Imputation by chained equations inR, J Stat Softw, 45, 10.18637/jss.v045.i03 Rycroft, 2012, Epidemiology of chronic obstructive pulmonary disease: a literature review, Int J Chron Obstruct Pulmon Dis, 7, 457, 10.2147/COPD.S32330 Schols, 2005, Body composition and mortality in chronic obstructive pulmonary disease, Am J Clin Nutr, 82, 53, 10.1093/ajcn/82.1.53 Jones, 2015, Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation, Thorax, 70, 213, 10.1136/thoraxjnl-2014-206440 Swallow, 2007, Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease, Thorax, 62, 115, 10.1136/thx.2006.062026 Roig, 2011, Deficits in muscle strength, mass, quality, and mobility in people with chronic obstructive pulmonary disease, J Cardiopulm Rehabil Prev, 31, 120, 10.1097/HCR.0b013e3181f68ae4 von Haehling, 2014, Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014, J Cachexia Sarcopenia Muscle, 5, 261, 10.1007/s13539-014-0164-8 Remels, 2013, The mechanisms of cachexia underlying muscle dysfunction in COPD, J Appl Physiol, 114, 1253, 10.1152/japplphysiol.00790.2012 Walters, 2005, Oral corticosteroids for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 3 Horita, 2014, Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease, Respir Res, 15, 37, 10.1186/1465-9921-15-37 Peters, 2020, COVID-19 related genes in sputum cells in asthma: relationship to demographic features and corticosteroids, Am J Respir Crit Care Med, 10.1164/rccm.202003-0821OC Group, 2020, Dexamethasone in hospitalized patients with Covid-19 - preliminary report, N Engl J Med Tan, 2020, Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study, Signal Transduct Target Ther, 5 Reese, 2019, Coordinated-transitional care for veterans with heart failure and chronic lung disease, J Am Geriatr Soc, 67, 1502, 10.1111/jgs.15978 Richardson, 2020, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area, JAMA, 323, 2052, 10.1001/jama.2020.6775 Colbenson, 2019, Post-intensive care syndrome: impact, prevention, and management, Breathe (Sheff), 15, 98, 10.1183/20734735.0013-2019 Cazzola, 2010, Prevalence of comorbidities in patients with chronic obstructive pulmonary disease, Respiration, 80, 112, 10.1159/000281880 Soler-Cataluña, 2005, Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease, Thorax, 60, 925, 10.1136/thx.2005.040527 Hurst, 2010, Susceptibility to exacerbation in chronic obstructive pulmonary disease, N Engl J Med, 363, 1128, 10.1056/NEJMoa0909883 Radeos, 2009, Validation of self-reported chronic obstructive pulmonary disease among patients in the ED, Am J Emerg Med, 27, 191, 10.1016/j.ajem.2008.01.011 Murgia, 2014, Validity of a questionnaire-based diagnosis of chronic obstructive pulmonary disease in a general population-based study, BMC Pulm Med, 14, 49, 10.1186/1471-2466-14-49 Barr, 2002, Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses, Am J Epidemiol, 155, 965, 10.1093/aje/155.10.965